Our Stories of Impact

New study reveals breast cancer drug combination has impact on other cancers

Photo: Professor Roisin Connolly, Director of Cancer Research at University College Cork.

Drug commonly used to treat HER2-positive breast cancer sees tumour shrinkage in several other cancer types.
Cancer treatment combination may have more uses than previously thought.

Previous Article Next Article

Back to Our Stories of Impact

UCC Futures

Todhchaíochtaí UCC

Office of Vice President for Research and Innovation | 4th Floor | Block E, Food Science Building | UCC,

Top